scispace - formally typeset
Journal ArticleDOI

A novel regional citrate anticoagulation protocol for CRRT using only commercially available solutions

Reads0
Chats0
TLDR
It is possible to provide safe and effective CRA with only commercially available solutions for units that do not want or cannot prepare extemporaneously made solutions.
About
This article is published in Journal of Critical Care.The article was published on 2003-06-01. It has received 71 citations till now.

read more

Citations
More filters
Journal ArticleDOI

Clinical review: Patency of the circuit in continuous renal replacement therapy

TL;DR: Non-anticoagulant and anticoaggulant measures to prevent circuit failure and regional anticoagulation with citrate emerges as the most promising method.
Journal ArticleDOI

Sustained low-efficiency dialysis in the ICU: Cost, anticoagulation, and solute removal

TL;DR: Sustained low-efficiency daily dialysis may be routinely performed without anticoagulation; it provides solute removal equivalent to CRRT at significantly lower cost.
Journal ArticleDOI

Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based?

TL;DR: The implementation of regional anticoagulation with citrate is worthwhile to reduce bleeding risk and future trials should be randomized and have sufficient power and well defined endpoints to compensate for the complexity of critical illness-related pro- and antICOagulant forces.
Journal ArticleDOI

Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice

TL;DR: Evidence has accumulated that regional anticoagulation of the CRRT circuit with citrate is feasible and safe, and citrate should become the first choice antICOagulant for CRRT provided that its safe use can be guaranteed.
References
More filters
Journal ArticleDOI

Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients

TL;DR: In 2,000 hours of citrate CAVHD in eleven critically patients, this system has proved smooth, practical and effective, and has minimized the risks of hemorrhage and thrombocytopenia encountered with heparin use.
Journal ArticleDOI

Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding

TL;DR: Two patients, one with septic shock and the other with fulminant hepatic failure, developed evidence for citrate toxicity without a significant alteration in clinical status, and this simplified technique of regional anticoagulation with citrate is an effective and safe form of antICOagulation for CVVH in critically ill patients with a high risk of bleeding.
Journal ArticleDOI

Effect of anticoagulation on blood membrane interactions during hemodialysis

TL;DR: The results of this investigation indicate that using sodium citrate as an anticoagulant during hemodialysis induces a lower activation of coagulation than both conventional and fractionated heparin, which might contribute to an improvement of biocompatibility of he modialysis extracorporeal circulation.
Journal ArticleDOI

Regional citrate anticoagulation in continuous venovenous hemodiafiltration

TL;DR: Guiding regional citrate anticoagulation through the use of posthemofilter ionized calcium levels is a safe and effective method of prolonging filter life during CVVHDF.
Journal ArticleDOI

Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients.

TL;DR: The data suggest that the use of RF-bic during CVVH reduces cardiovascular events in critically ill patients with acute renal failure, particularly those with previous cardiovascular disease or heart failure, and that the administration of RF -bic solution was superior in normalizing acidosis of patients without the risk of alkalosis.
Related Papers (5)